Percutaneous Mitral Balloon Valvuloplasty: Technique and Results
Asian Journal of Medicine and Health,
Background: Percutaneous balloon mitral valvuloplasty is a procedure used to dilate the mitral valve in cases of rheumatic mitral stenosis. The catheter is inserted into the female vein to the right atrium and atrial septum. The mitral valve is then passed through the inflated balloon to facilitate effective integration of mitral adhesions, which increases the area of the mitral valve and decreases the rate of mitral stenosis. Mitral regurgitation is a potential problem, and thus balloon percutaneous mitral valvuloplasty (PBMV) is prevented in moderate to severe relapse. The Wilkins score studies mitral valve morphology and evaluation by echocardiography to assess the viability of PBMVs based on specific echocardiographic conditions.
Conclusion: There are many factors in the immediate and long-term outcomes of patients undergoing PMV. Echo-Sc can be used in combination with other clinical and morphological predictions of PMV effects to identify patients who experience the best effects on PMV.
- Mitral stenosis
- percutaneous mitral balloon valvuloplasty
- mitral valve surgery
How to Cite
Rinkevich D., Lessick J., Mutlak D., Markiewicz W., Reisner S.A. Natural history of moderate mitral valve stenosis. Isr Med. Assoc. J. 2003;5(1):15–18.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease, executive summary, a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):2440–2492.
Carroll JD, Feldman T. Percutaneous mitral balloon valvotomy and the new demographics of mitral stenosis. JAMA. 1993;270(14):1731–1736.
Orrange SE, Kawanishi DT, Lopez BM, Curry SM, Rahimtoola SH. Actuarial outcome after catheter balloon commissurotomy in patients with mitral stenosis. Circulation. 1997;95(2): 382–389.
Ellis LB, Singh JB, Morales DD, Harken DE. Fifteen-to twenty-year study of one thousand patients undergoing closed mitral valvuloplasty. Circulation. 1973;48(2):357–364.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J. Am. Coll. Cardiol. 2017;70(2):252–289.
J. Cohen, A coefficient of agreement for nominal scales educational and psychological measurement (EPM). 1960;20(1):37–46.
Fawzy ME. Percutaneous mitral balloon valvotomy. Catheterization Cardiovascular Interventions, off. J. Society for Cardiac Angiography & Interventions. 2007;69(2): 313–321.
Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J. Thorac. Cardiovasc. Surg. 1984;87(3):394–402.
Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block P.C. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105(12):1465–1471.
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H. Guidelines on the management of valvular heart disease (version 2012) Eur. Heart J. 2012;33(19):2451–2496.
Bouleti C, Iung B, Himbert D, Brochet E, Messika-Zeitoun D, Détaint D. Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years, the role of repeat percutaneous mitral commissurotomy. Eur. Heart J. 2013;34(25):1923–1930.
Chmielak Z, Kłopotowski M, Demkow M, Konka M, Hoffman P, Kukuła K. Percutaneous mitral balloon valvuloplasty beyond 65 years of age. Cardiol. J. 2013;20(1):44–51.
Jorge E, Pan M, Baptista R, Romero M, Ojeda S, Suárez de Lezo J. Predictors of very late events after percutaneous mitral valvuloplasty in patients with mitral stenosis. Am. J. Cardiol. 2016;117(12):1978–1984.
Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105(12):1465-71.
Hernandez R, Banuelos C, Alfonso F, et al. Long-term clinical and echocardiographic follow-up after percutaneous mitral valvuloplasty with the Inoue balloon. Circulation. 1999. 99(12):1580-6.
Complications and mortality of percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry. Circulation. 1992;85(6):2014-24.
Tomai F, Gaspardone A, Versaci F, Ghini AS, Altamura L, De Luca L, et al. Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. Int J Cardiol. 2014;177 (3):881-5.
Rifaie O, Esmat I, Abdel-Rahman M, Nammas W. Can a novel echocardiographic score better predict outcome after percutaneous balloon mitral valvuloplasty?. Echocardiography. 2009; 26(2):119-27.
Han J, Tian B, Wu F, et al. Surgical rheumatic mitral valve repair compared with percutaneous balloon mitral valvuloplasty in mitral stenosis in current era: a propensity score matching study. J Thorac Dis. 2020;12 (11):6752-60.
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused update of the 2014 AHA/ACC guideline for the management of patients With valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 Jul 11. 70 (2):252-89.
Hildick-Smith DJ, Taylor GJ, Shapiro LM. Inoue balloon mitral valvuloplasty: long-term clinical and echocardiographic follow-up of a predominantly unfavourable population. Eur Heart J. Oct 2000. 21(20):1690-7.
Abstract View: 114 times
PDF Download: 37 times